Literature DB >> 6607807

XX T cells and XY B cells in two patients with severe combined immune deficiency.

M E Conley, P C Nowell, G Henle, S D Douglas.   

Abstract

Immunologic evaluation of two unrelated male infants with clinical and laboratory evidence of severe combined immunodeficiency (SCID) revealed T cells with a mature phenotype in the peripheral circulation of both patients although both had biopsy evidence of thymic alymphoplasia. Both had a normal number of T cells with a cytotoxic/suppressor surface marker (OKT8) but very few T helper cells (OKT4). Lymphocyte stimulation with the mitogens PHA, Con A, and pokeweed or with allogeneic cells resulted in no proliferation. However, addition of T cell growth factor, plus the phorbol ester TPA, to lymphocytes cultured with the T cell mitogen PHA did result in some proliferation of T cells. In both cases these T cells demonstrated an XX female karyotype and were probably of maternal origin. In contrast, proliferating B cells stimulated with Epstein-Barr virus demonstrated a normal XY male karyotype. The possibility that severe combined immune deficiency in these patients was the result of graft-versus-host disease induced by maternal lymphocytes is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6607807     DOI: 10.1016/0090-1229(84)90192-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

1.  Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling.

Authors:  S Toyabe; A Watanabe; W Harada; T Karasawa; M Uchiyama
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

2.  Accelerated development of immunity following transplantation of maternal marrow stem cells into infants with severe combined immunodeficiency and transplacentally acquired lymphoid chimerism.

Authors:  M J Barrett; R H Buckley; S E Schiff; P C Kidd; F E Ward
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

3.  Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation.

Authors:  J M Puck; R L Nussbaum; M E Conley
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

4.  X-linked severe combined immunodeficiency. Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findings.

Authors:  M E Conley; R H Buckley; R Hong; C Guerra-Hanson; C M Roifman; J A Brochstein; S Pahwa; J M Puck
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

5.  DNA-based HLA typing of nonhematopoietic tissue used to select the marrow transplant donor for successful treatment of transfusion-associated graft-versus-host disease.

Authors:  D F Friedman; P Kwittken; B Cizman; E Argyris; J Kearns; S Y Yang; C Zmijewski; N Bunin; S D Douglas; D Monos
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

6.  Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency.

Authors:  A E Pepper; R H Buckley; T N Small; J M Puck
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.